参考文献:1.Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29(1):251–6.CrossRef PubMed 2.Inagawa T. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998. Stroke. 2001;32(7):1499–507.CrossRef PubMed 3.Broderick JP, Viscoli CM, Brott T, Kernan WN, Brass LM, Feldmann E, et al. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34(6):1375–81. doi:10.1161/01.STR.0000074572.91827.F4 .CrossRef PubMed 4.Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol. 2005;4(3):179–89. doi:10.1016/S1474-4422(05)01015-X .CrossRef PubMed 5.Nahed BV, Bydon M, Ozturk AK, Bilguvar K, Bayrakli F, Gunel M. Genetics of intracranial aneurysms. Neurosurgery. 2007;60(2):213–25. doi:10.1227/01.NEU.0000249270.18698.BB . discussion 25-6.CrossRef PubMed 6.Foroud T, Lai D, Koller D, Van’t Hof F, Kurki MI, Anderson CS, et al. Genome-wide association study of intracranial aneurysm identifies a new association on chromosome 7. Stroke. 2014;45(11):3194–9. doi:10.1161/STROKEAHA.114.006096 .CrossRef PubMedCentral PubMed 7.Bakir-Gungor B, Sezerman OU. The identification of pathway markers in intracranial aneurysm using genome-wide association data from two different populations. PLoS One. 2013;8(3):e57022. doi:10.1371/journal.pone.0057022 .CrossRef PubMedCentral PubMed 8.Low SK, Takahashi A, Cha PC, Zembutsu H, Kamatani N, Kubo M, et al. Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA. Hum Mol Genet. 2012;21(9):2102–10. doi:10.1093/hmg/dds020 .CrossRef PubMed 9.Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet. 2010;42(5):420–5. doi:10.1038/ng.563 .CrossRef PubMedCentral PubMed 10.Smalinskiene A, Petkeviciene J, Luksiene D, Jureniene K, Klumbiene J, Lesauskaite V. Association between APOE, SCARB1, PPARalpha polymorphisms and serum lipids in a population of Lithuanian adults. Lipids Health Dis. 2013;12:120. doi:10.1186/1476-511X-12-120 .CrossRef PubMedCentral PubMed 11.Boulenouar H, Mediene Benchekor S, Meroufel DN, Lardjam Hetraf SA, Ouhaibi Djellouli H, Hermant X, et al. Impact of APOE gene polymorphisms on the lipid profile in an Algerian population. Lipids Health Dis. 2013;12:155. doi:10.1186/1476-511X-12-155 .CrossRef PubMedCentral PubMed 12.Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155(6):487–95.CrossRef PubMed 13.Lebedeva ER, Sakovich VP, Khusainova RI, Kutuev IA, Valiev RR, Khusnutdinova NN, et al. The role of angiotensin-converting enzyme and apolipoprotein E in the development of intracranial aneurysms. Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(10):52–7.PubMed 14.Mineharu Y, Inoue K, Inoue S, Yamada S, Nozaki K, Takenaka K, et al. Association analysis of common variants of ELN, NOS2A, APOE and ACE2 to intracranial aneurysm. Stroke. 2006;37(5):1189–94. doi:10.1161/01.STR.0000217408.91389.4d .CrossRef PubMed 15.Glasker S, Schatlo B, Klingler JH, Braun V, Spangenberg P, Kim IS, et al. Associations of collagen type I alpha2 polymorphisms with the presence of intracranial aneurysms in patients from Germany. J Stroke Cerebrovasc Dis. 2014;23(2):356–60. doi:10.1016/j.jstrokecerebrovasdis.2013.04.038 .CrossRef PubMed 16.Li LJ, Pan XM, Sima X, Li ZH, Zhang LS, Sun H, et al. Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm. Mol Biol Rep. 2012;39(12):11217–23. doi:10.1007/s11033-012-2031-z .CrossRef PubMed 17.Zheng S, Su A, Sun H, You C. The association between interleukin-6 gene polymorphisms and intracranial aneurysms: a meta-analysis. Hum Immunol. 2013;74(12):1679–83. doi:10.1016/j.humimm.2013.08.274 .CrossRef PubMed 18.Li L, Sima X, Bai P, Zhang L, Sun H, Liang W, et al. Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm. Clin Dev Immunol. 2012;2012:567586. doi:10.1155/2012/567586 .PubMedCentral PubMed 19.Yang S, Wang T, You C, Liu W, Zhao K, Sun H, et al. Association of polymorphisms in the elastin gene with sporadic ruptured intracranial aneurysms and unruptured intracranial aneurysms in Chinese patients. Int J Neurosci. 2013;123(7):454–8. doi:10.3109/00207454.2013.763803 .CrossRef PubMed 20.McColgan P, Thant KZ, Sharma P. The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals. J Neurosurg. 2010;112(4):714–21. doi:10.3171/2009.8.JNS092 .CrossRef PubMed 21.Sima X, Xu J, Li J, You C. Association between NFKB1 -94 insertion/deletion ATTG polymorphism and risk of intracranial aneurysm. Genet Test Mol Biomarkers. 2013;17(8):620–4. doi:10.1089/gtmb.2013.0110 .CrossRef PubMedCentral PubMed 22.Weinsheimer S, Goddard KA, Parrado AR, Lu Q, Sinha M, Lebedeva ER, et al. Association of kallikrein gene polymorphisms with intracranial aneurysms. Stroke. 2007;38(10):2670–6. doi:10.1161/STROKEAHA.107.486225 .CrossRef PubMed 23.Liu Y, Li P, Hu X, Hu Y, Sun HG, Ma WC, et al. Angiotensin-converting enzyme insertion/deletion gene polymorphism and risk of intracranial aneurysm in a Chinese population. J Int Med Res. 2013;41(4):1079–87. doi:10.1177/0300060513487625 .CrossRef PubMed 24.Chen Z, Ma J, Cen Y, Liu Y, You C. The angiotensin converting enzyme insertion/deletion polymorphism and intracranial aneurysm: a meta-analysis of case-control studies. Neurol India. 2013;61(3):293–9. doi:10.4103/0028-3886.115071 .CrossRef PubMed 25.Pannu H, Kim DH, Guo D, King TM, Van Ginhoven G, Chin T, et al. The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms. J Neurosurg. 2006;105(3):418–23. doi:10.3171/jns.2006.105.3.418 .CrossRef PubMed 26.Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke. 1999;30(12):2612–6.CrossRef PubMed 27.Yin YW, Li JC, Wang JZ, Li BH, Pi Y, Yang QW, et al. Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis. Neurosci Lett. 2012;514(1):6–11. doi:10.1016/j.neulet.2012.02.031 .CrossRef PubMed 28.Rubino E, Vacca A, Govone F, De Martino P, Pinessi L, Rainero I. Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: a meta-analysis. Alzheimers Demen. 2013;9(6):706–13. doi:10.1016/j.jalz.2012.10.013 .CrossRef 29.Yu B, Chen W, Wang R, Qi Q, Li K, Zhang W, et al. Association of apolipoprotein E polymorphism with maximal oxygen uptake after exercise training: a study of Chinese young adult. Lipids Health Dis. 2014;13(1):40. doi:10.1186/1476-511X-13-40 .CrossRef PubMedCentral PubMed 30.Zhou TB, Qin YH, Xu HL. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies. Mol Biol Rep. 2012;39(10):9347–54. doi:10.1007/s11033-012-1751-4 .CrossRef PubMed 31.Stoumpos S, Hamodrakas SJ, Anthopoulos PG, Bagos PG. The association between apolipoprotein E gene polymorphisms and essential hypertension: a meta-analysis of 45 studies including 13,940 cases and 16,364 controls. J Hum Hypertens. 2013;27(4):245–55. doi:10.1038/jhh.2012.37 .CrossRef PubMed 32.Zhu S, Wang Z, Wu X, Shu Y, Lu D. Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation. Lipids Health Dis. 2014;13:21. doi:10.1186/1476-511X-13-21 .CrossRef PubMedCentral PubMed 33.Han Y, Liu T, Lu L. Apolipoprotein E gene polymorphism in psoriasis: a meta-analysis. Arch Med Res. 2013;44(1):46–53. doi:10.1016/j.arcmed.2012.10.009 .CrossRef PubMed 34.Meng HX, Qi MG, Yi YY, Liu YP. Association between apolipoprotein E gene polymorphism and the risk of recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet. 2013;30(12):1547–52. doi:10.1007/s10815-013-0118-7 .CrossRef PubMedCentral PubMed 35.Yin YW, Zhang YD, Wang JZ, Li BH, Yang QW, Fang CQ, et al. Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects. Gene. 2012;511(1):12–7. doi:10.1016/j.gene.2012.09.010 .CrossRef PubMed 36.Wang QY, Wang WJ, Wu L, Liu L, Han LZ. Meta-analysis of APOE epsilon2/epsilon3/epsilon4 polymorphism and cerebral infarction. J Neural Transm. 2013;120(10):1479–89. doi:10.1007/s00702-013-1019-8 .CrossRef PubMed 37.Gong JS, Kobayashi M, Hayashi H, Zou K, Sawamura N, Fujita SC, et al. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem. 2002;277(33):29919–26. doi:10.1074/jbc.M203934200 .CrossRef PubMed 38.Fagan AM, Holtzman DM, Munson G, Mathur T, Schneider D, Chang LK, et al. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J Biol Chem. 1999;274(42):30001–7.CrossRef PubMed 39.Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999;19(12):4867–80.PubMed 40.Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994;264(5160):850–2.CrossRef PubMed 41.Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem. 1995;270(45):27063–71.CrossRef PubMed 42.Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Ye GL, et al. ApoE isoform affects LTP in human targeted replacement mice. Neuroreport. 2004;15(17):2655–8.CrossRef PubMed 43.Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, et al. Mitochondrial damage in Alzheimer’s disease varies with apolipoprotein E genotype. Ann Neurol. 2000;48(3):297–303.CrossRef PubMed 44.Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci U S A. 2004;101(1):284–9. doi:10.1073/pnas.2635903100 .CrossRef PubMedCentral PubMed 45.Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010;68(6):934–43. doi:10.1002/ana.22134 .CrossRef PubMedCentral PubMed
作者单位:Hao Liu (1) Ping Mao (1) Changhou Xie (1) Wanfu Xie (1) Maode Wang (1) Haitao Jiang (1)
1. Department of Neurosurgery, The First Affiliated Hospital of Xi’an Jiao Tong University, West Yanta Road No.277, Xi’an, 710061, China
刊物主题:Neurology; Neurochemistry; Neurosurgery;
出版者:BioMed Central
ISSN:1471-2377
文摘
Background The relationship between the apolipoprotein E (APOE) polymorphism and intracranial aneurysms has previously only been studied in Russia and Japan but not in Chinese populations. The purpose of this study was to investigate the association between APOE polymorphism and the risk of intracranial aneurysms in a Chinese population.